Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valacyclovir for Severe Periodontitis
NCT05712343Phase 1Unknown
- Sponsor
- University of California, San Francisco
- Start
- May 2023
- Primary completion
- Mar 2024
- Modality
- Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of valaciclovir in periodontitis (2 arms), sponsored by University of California, San Francisco. Primary endpoints: Clinical attachment level at 6 months, Periodontal pocket depth at 6 months and 1 more. Status: unknown.
02
Drugs
valaciclovir
03
Conditions
periodontitis
Beyond the preview
Go deeper on NCT05712343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05712343.